These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34278466)

  • 1. Chemokine CCL20 promotes the paclitaxel resistance of CD44
    Chen M; Su J; Feng C; Liu Y; Zhao L; Tian Y
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of characteristics of CD44+CD117+ ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures.
    Chen J; Wang J; Chen D; Yang J; Yang C; Zhang Y; Zhang H; Dou J
    BMC Cell Biol; 2013 Jan; 14():7. PubMed ID: 23368632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD109 Promotes Drug Resistance in A2780 Ovarian Cancer Cells by Regulating the STAT3-NOTCH1 Signaling Axis.
    Kim JS; Shin MJ; Lee SY; Kim DK; Choi KU; Suh DS; Kim D; Kim JH
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KHDRBS3 promotes paclitaxel resistance and induces glycolysis through modulated MIR17HG/CLDN6 signaling in epithelial ovarian cancer.
    Wu X; Qiu L; Feng H; Zhang H; Yu H; Du Y; Wu H; Zhu S; Ruan Y; Jiang H
    Life Sci; 2022 Mar; 293():120328. PubMed ID: 35051418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin-stimulated macrophages promote ovarian cancer migration via the CCL20-CCR6 axis.
    Liu W; Wang W; Wang X; Xu C; Zhang N; Di W
    Cancer Lett; 2020 Mar; 472():59-69. PubMed ID: 31866467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.
    Guo W; Li H; Liu H; Ma X; Yang S; Wang Z
    Oncol Rep; 2019 Sep; 42(3):1075-1089. PubMed ID: 31322256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
    Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
    Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel targeted co-delivery nanosystem for enhanced ovarian cancer treatment via multidrug resistance reversion and mTOR-mediated signaling pathway.
    Wang X; Xiong T; Cui M; Li N; Li Q; Zhu L; Duan S; Wang Y; Guo Y
    J Nanobiotechnology; 2021 Dec; 19(1):444. PubMed ID: 34949180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted inhibition of phosphatidyl inositol-3-kinase p110β, but not p110α, enhances apoptosis and sensitivity to paclitaxel in chemoresistant ovarian cancers.
    Jeong JY; Kim KS; Moon JS; Song JA; Choi SH; Kim KI; Kim TH; An HJ
    Apoptosis; 2013 Apr; 18(4):509-20. PubMed ID: 23371322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNA‑u50535 promotes the progression of lung cancer by activating CCL20/ERK signaling.
    Wei W; Zhao X; Zhu J; Zhang L; Chen Y; Zhang B; Li Y; Wang M; Zhang Z; Wang C
    Oncol Rep; 2019 Nov; 42(5):1946-1956. PubMed ID: 31545478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of androgen receptor signaling induces prostate cancer migration via activation of the CCL20-CCR6 axis.
    Kano H; Izumi K; Hiratsuka K; Toriumi R; Nakagawa R; Aoyama S; Kamijima T; Shimada T; Naito R; Kadomoto S; Iwamoto H; Yaegashi H; Kawaguchi S; Nohara T; Shigehara K; Kadono Y; Saito Y; Nakagawa-Goto K; Yoshioka K; Nakata H; Lin WJ; Mizokami A
    Cancer Sci; 2023 Apr; 114(4):1479-1490. PubMed ID: 36479732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.
    Byeon Y; Lee JW; Choi WS; Won JE; Kim GH; Kim MG; Wi TI; Lee JM; Kang TH; Jung ID; Cho YJ; Ahn HJ; Shin BC; Lee YJ; Sood AK; Han HD; Park YM
    Cancer Res; 2018 Nov; 78(21):6247-6256. PubMed ID: 30115698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of Krüppel-like factor 9 facilitates stemness in ovarian cancer ascites-derived multicellular spheroids via Notch1/slug signaling.
    Wang K; Liu S; Dou Z; Zhang S; Yang X
    Cancer Sci; 2021 Oct; 112(10):4220-4233. PubMed ID: 34363722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel-loaded hyaluronan solid nanoemulsions for enhanced treatment efficacy in ovarian cancer.
    Kim JE; Park YJ
    Int J Nanomedicine; 2017; 12():645-658. PubMed ID: 28176896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling.
    Chau WK; Ip CK; Mak AS; Lai HC; Wong AS
    Oncogene; 2013 May; 32(22):2767-81. PubMed ID: 22797058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.
    Cheng W; Liu T; Wan X; Gao Y; Wang H
    FEBS J; 2012 Jun; 279(11):2047-59. PubMed ID: 22498306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.
    Ma L; Lai D; Liu T; Cheng W; Guo L
    Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):593-602. PubMed ID: 20705681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly expressed STAT1 contributes to the suppression of stemness properties in human paclitaxel-resistant ovarian cancer cells.
    Wang F; Zhang L; Liu J; Zhang J; Xu G
    Aging (Albany NY); 2020 Jun; 12(11):11042-11060. PubMed ID: 32516753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overview.
    Frick VO; Rubie C; Keilholz U; Ghadjar P
    World J Gastroenterol; 2016 Jan; 22(2):833-41. PubMed ID: 26811629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL20/CCR6 chemokine/receptor expression in bone tissue from osteoarthritis and rheumatoid arthritis patients: different response of osteoblasts in the two groups.
    Lisignoli G; Manferdini C; Codeluppi K; Piacentini A; Grassi F; Cattini L; Filardo G; Facchini A
    J Cell Physiol; 2009 Oct; 221(1):154-60. PubMed ID: 19492413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.